189 related articles for article (PubMed ID: 12846420)
1. HER2 codon 655 polymorphism and risk of breast cancer in African Americans and whites.
Millikan R; Eaton A; Worley K; Biscocho L; Hodgson E; Huang WY; Geradts J; Iacocca M; Cowan D; Conway K; Dressler L
Breast Cancer Res Treat; 2003 Jun; 79(3):355-64. PubMed ID: 12846420
[TBL] [Abstract][Full Text] [Related]
2. Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.
Xie D; Shu XO; Deng Z; Wen WQ; Creek KE; Dai Q; Gao YT; Jin F; Zheng W
J Natl Cancer Inst; 2000 Mar; 92(5):412-7. PubMed ID: 10699071
[TBL] [Abstract][Full Text] [Related]
3. A case-control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer.
Nelson SE; Gould MN; Hampton JM; Trentham-Dietz A
Breast Cancer Res; 2005; 7(3):R357-64. PubMed ID: 15987431
[TBL] [Abstract][Full Text] [Related]
4. Ile to Val polymorphism at codon 655 of HER-2 gene and breast cancer risk in Iranian women.
Kamali-Sarvestani E; Talei AR; Merat A
Cancer Lett; 2004 Nov; 215(1):83-7. PubMed ID: 15374636
[TBL] [Abstract][Full Text] [Related]
5. A case-control study of the HER2 Ile655Val polymorphism and risk of breast cancer in Taiwan.
Lee SC; Hou MF; Hsieh PC; Wu SH; Hou LA; Ma H; Tsai SM; Tsai LY
Clin Biochem; 2008 Feb; 41(3):121-5. PubMed ID: 18062925
[TBL] [Abstract][Full Text] [Related]
6. Association between the HER2 Ile655Val polymorphism and response to trastuzumab in women with operable primary breast cancer.
Han X; Diao L; Xu Y; Xue W; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
Ann Oncol; 2014 Jun; 25(6):1158-64. PubMed ID: 24608202
[TBL] [Abstract][Full Text] [Related]
7. HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.
Watrowski R; Castillo-Tong DC; Wolf A; Schuster E; Fischer MB; Speiser P; Zeillinger R
Anticancer Res; 2015 Nov; 35(11):5901-4. PubMed ID: 26504013
[TBL] [Abstract][Full Text] [Related]
8. HER2 codon 655 polymorphism and breast cancer risk: a meta-analysis.
Tao W; Wang C; Han R; Jiang H
Breast Cancer Res Treat; 2009 Mar; 114(2):371-6. PubMed ID: 18438707
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study.
Mechanic LE; Millikan RC; Player J; de Cotret AR; Winkel S; Worley K; Heard K; Heard K; Tse CK; Keku T
Carcinogenesis; 2006 Jul; 27(7):1377-85. PubMed ID: 16399771
[TBL] [Abstract][Full Text] [Related]
10. HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.
Watrowski R; Castillo-Tong DC; Wolf A; Schuster E; Fischer MB; Speiser P; Zeillinger R
Anticancer Res; 2015 Dec; 35(12):6667-70. PubMed ID: 26637882
[TBL] [Abstract][Full Text] [Related]
11. Lack of association between HER2 codon 655 polymorphism and breast cancer susceptibility: meta-analysis of 22 studies involving 19,341 subjects.
Ma Y; Yang J; Zhang P; Liu Z; Yang Z; Qin H
Breast Cancer Res Treat; 2011 Jan; 125(1):237-41. PubMed ID: 20524057
[TBL] [Abstract][Full Text] [Related]
12. HER-2/neu gene codon 655 (Ile/Val) polymorphism in breast carcinoma patients.
Sezgin E; Sahin FI; Yagmurdur MC; Demirhan B
Genet Test Mol Biomarkers; 2011 Mar; 15(3):143-6. PubMed ID: 21204706
[TBL] [Abstract][Full Text] [Related]
13. 5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites.
Keku T; Millikan R; Worley K; Winkel S; Eaton A; Biscocho L; Martin C; Sandler R
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1611-21. PubMed ID: 12496052
[TBL] [Abstract][Full Text] [Related]
14. P53 codon 72 and HER2 codon 655 polymorphisms in Turkish breast cancer patients.
Kara N; Karakus N; Ulusoy AN; Ozaslan C; Gungor B; Bagci H
DNA Cell Biol; 2010 Jul; 29(7):387-92. PubMed ID: 20380571
[TBL] [Abstract][Full Text] [Related]
15. HER2 Ile655Val polymorphism contributes to breast cancer risk: evidence from 27 case-control studies.
Lu S; Wang Z; Liu H; Hao X
Breast Cancer Res Treat; 2010 Dec; 124(3):771-8. PubMed ID: 20401632
[TBL] [Abstract][Full Text] [Related]
16. HER-2 [Ile655Val] polymorphism in association with breast cancer risk: a population-based case-control study in Slovakia.
Zúbor P; Vojvodová A; Danko J; Kajo K; Szunyogh N; Lasabová Z; Biringer K; Visnovský J; Dókus K; Galajda P; Plank L
Neoplasma; 2006; 53(1):49-55. PubMed ID: 16416013
[TBL] [Abstract][Full Text] [Related]
17. No association between HER-2 gene polymorphism at codon 655 and a risk of bladder cancer.
Wang L; Habuchi T; Takahashi T; Kamoto T; Zuo T; Mitsumori K; Tsuchiya N; Sato K; Ogawa O; Kato T
Int J Cancer; 2002 Feb; 97(6):787-90. PubMed ID: 11857355
[TBL] [Abstract][Full Text] [Related]
18. Association of HER2 codon 655 polymorphism with ovarian cancer.
Watrowski R; Castillo-Tong DC; Schuster E; Fischer MB; Speiser P; Zeillinger R
Tumour Biol; 2016 Jun; 37(6):7239-44. PubMed ID: 26666819
[TBL] [Abstract][Full Text] [Related]
19. HER2Ile655Val Single Nucleotide Polymorphism Associated with Early-Onset Breast Cancer Susceptibility: A Systematic Review and Meta-Analysis.
Nguyen Thanh T; Nguyen Tran BS; Hoang Thi AP; Tran Binh T; Ba Nguyen T; Le Minh T; Nguyen Vu QH; Dang Cong T
Asian Pac J Cancer Prev; 2021 Jan; 22(1):11-18. PubMed ID: 33507673
[TBL] [Abstract][Full Text] [Related]
20. Allelic imbalance of HER-2 codon 655 polymorphism among different religious/ethnic populations of northern Greece and its association with the development and the malignant phenotype of breast cancer.
Papadopoulou E; Simopoulos K; Tripsianis G; Tentes I; Anagnostopoulos K; Sivridis E; Galazios G; Kortsaris A
Neoplasma; 2007; 54(5):365-73. PubMed ID: 17918664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]